Johan Goossens, the non-executive director of Cryo-Save, has taken advantage of the recent slump in the stem cell storage firm's share price by increasing his stake to over 16%.
Goossens spent £116,000 to buy 800,000 shares at 14.5p each, increasing his stake to 7.5m shares, or 16.21%.
Shares in last month have fallen by over a half in the group after it scaled back expectations for the second half and beyond due to the recent economic turmoil.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
It expects samples stored for the second half to be broadly in line with the 12,537 stored in the first half, while profitability the following year will be 'significantly below market expectations'.
Top Director Buys
Value: £173,124
Value: £116,000
Value: £50,250
Value: £45,000
Value: £24,000
Value: £21,600
Value: £21,600
Value: £19,900
Value: £15,000
Value: € 12,697
Top Director Sells
Value: £791,560
Value: $79,600
Value: $73,900
Value: £10,139
-
Four AI ETFs to buyIs now a good time to buy AI ETFs? We examine four AI ETFs that investors might want to add to their portfolio
-
Chase boosts easy-access interest rate - savers could earn 4.75%Chase is offering a boosted interest rate which is fixed for six months, on top of the standard variable rate
